| 注册
首页|期刊导航|重庆医学|检测 ROC1在卵巢恶性上皮性肿瘤组织中的表达及临床意义研究

检测 ROC1在卵巢恶性上皮性肿瘤组织中的表达及临床意义研究

李娜 孙丽君 李东林 刘颂 高家志

重庆医学Issue(2):202-204,3.
重庆医学Issue(2):202-204,3.DOI:10.3969/j.issn.1671-8348.2016.02.018

检测 ROC1在卵巢恶性上皮性肿瘤组织中的表达及临床意义研究

Expression and clinical significance of ROC1 in women with epithelial ovarian cancer

李娜 1孙丽君 1李东林 2刘颂 1高家志1

作者信息

  • 1. 遵义医学院附属医院妇科,贵州遵义 563000
  • 2. 贵州省人民医院妇科,贵阳 550002
  • 折叠

摘要

Abstract

Objective To investigate the expression and clinical significance of ROC1 in ovarian cancer tissues ,to provide new ideas for the gene therapy of ovarian cancer .Methods 261 women with ovarian cancer underwent resection from December 2005 to December 2007 in the Affiliated Hospital of Zunyi Medical College and with 5 years follow-up were enrolled .ROC1 mRNA transcription and protein expression level of ovarian cancer tissue and surrounding normal tissue were tested ,and later the correla-tion between the results and patient′s prognosis was statistically analyzed .Results ROC1 in ovarian cancer tissue was over-ex-pressed ,but almost no expression in surrounding normal ovarian carcinoma ;ROC1 expression levels had a negative correlation with the survival rate of the patients .Conclusion ROC1 in ovarian cancer tissue was over-expressed ,but almost no expression in sur-rounding normal ovarian carcinoma ;ROC1 expression levels had a negative correlation with the survival rate of the patients .

关键词

ROC1/卵巢肿瘤/基因疗法/预后 ,存活率

Key words

ROC1/ovarian neoplasms/gene therapy/prognosis ,survival rate

分类

医药卫生

引用本文复制引用

李娜,孙丽君,李东林,刘颂,高家志..检测 ROC1在卵巢恶性上皮性肿瘤组织中的表达及临床意义研究[J].重庆医学,2016,(2):202-204,3.

基金项目

贵州省科技厅联合基金资助项目(黔科合J字LKZ[2012]50号)。 ()

重庆医学

OA北大核心

1671-8348

访问量1
|
下载量0
段落导航相关论文